Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | |
|---|---|---|---|
| Total revenue | |||
| Cost of revenue | |||
| Gross profit | |||
| Operating expense | -4.21%254.48K | 10.36%265.67K | 240.73K |
| Selling and administrative expenses | -4.21%254.48K | 10.36%265.67K | --240.73K |
| -General and administrative expense | -4.21%254.48K | 10.36%265.67K | --240.73K |
| Operating profit | 4.21%-254.48K | -10.36%-265.67K | -240.73K |
| Net non-operating interest income (expenses) | -29.61%309 | -71.29%439 | 1.53K |
| Non-operating interest income | -29.61%309 | -71.29%439 | --1.53K |
| Other net income (expenses) | -366.88%-909.34K | 109.19%340.73K | -3.71M |
| Other non-operating income (expenses) | -366.88%-909.34K | 109.19%340.73K | ---3.71M |
| Income before tax | -1,640.96%-1.16M | 101.91%75.51K | -3.95M |
| Income tax | 0 | 0 | 0 |
| Earnings from equity interest net of tax | |||
| Net income | -1,640.96%-1.16M | 101.91%75.51K | -3.95M |
| Net income continuous operations | -1,640.96%-1.16M | 101.91%75.51K | ---3.95M |
| Noncontrolling interests | |||
| Net income attributable to the company | -1,640.96%-1.16M | 101.91%75.51K | -3.95M |
| Preferred stock dividends | |||
| Other under preferred stock dividend | |||
| Net income attributable to common stockholders | -1,640.96%-1.16M | 101.91%75.51K | -3.95M |
| Diluted earnings per share | -1,675.00%-0.0063 | 101.85%0.0004 | -0.0216 |
| Basic earnings per share | -1,675.00%-0.0063 | 101.85%0.0004 | -0.0216 |
| Dividend per share | |||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP |